Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
2018 · Nature Medicine · 1,112 citations
https://doi.org/10.1038/s41591-018-0051-5
X
Xiaobo Mao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
7.4K
Citations
41
h-index
75
i10-index
Xiaobo Mao is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 41, co-authored 125 publications.
ORCID: 0000-0001-6587-556XPapers by this author
worksT cells from patients with Parkinson’s disease recognize α-synuclein peptides
2017 · Nature · 843 citations
https://doi.org/10.1038/nature22815
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
2018 · Science · 453 citations
https://doi.org/10.1126/science.aat8407
Nanomaterials for Reducing Amyloid Cytotoxicity
2013 · Advanced Materials · 181 citations
https://doi.org/10.1002/adma.201301210
PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
2021 · Science Translational Medicine · 63 citations
https://doi.org/10.1126/scitranslmed.aax8891
The effect of graphene oxide on conformation change, aggregation and cytotoxicity of HIV-1 regulatory protein (Vpr)
2012 · Biomaterials · 50 citations
https://doi.org/10.1016/j.biomaterials.2012.10.067
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat